(…) many clients are reluctant to to pursue additional diagnostics either due to expense or the procedures themselves. An accurate, non invasive method of pre screening would be an incredibly useful tool in daily practice. It could help to catch potentially cancerous masses while still treatable.
If it were possible (…) to reliably distinguish between neoplastic and non-neoplastic surface masses with a noninvasive imaging technique (…), such a capability could revolutionize the way veterinarians address skin surface lesions, (…) eliminat[ing] the need for further diagnostics, surgery and the attendant concern and expense involved.
Already, others like Scopio Labs and PathAI harness AI technology to arrive at diagnoses (…) With [Lynx]'s preliminary work, I'm very intrigued by the prospect of being able to offer a visually-based alternative to clinical cytology with a cell-phone app.
Madison Page
Founder and Chief Executive Officer
After working two-years as a veterinary assistant, Madison started Lynx in 2022. Previously, she worked as a Content Creator and Website Editorial Project Coordinator for the Pet Cancer Foundation.
Dr. Derick Whitley
Veterinary Advisor
Dr. Whitley is a veterinary pathologist. He is a Venture Partner for Vetted Capital and has a background in dermatopathology and developing image analysis machine learning models.
